首页 | 本学科首页   官方微博 | 高级检索  
     


Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study
Authors:Katharine N. Sourbeer  Lauren E. Howard  Gerald L. Andriole  Daniel M. Moreira  Ramiro Castro‐Santamaria  Stephen J. Freedland  Adriana C. Vidal
Affiliation:1. Urology Section, Veterans Affairs Medical Center, Durham, NC, USA;2. Division of Urology, Department of Surgery, Duke Prostate Center, Duke University School of Medicine, Durham, NC, USA;3. Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO, USA;4. The Arthur Smith Institute for Urology, North Shore Long Island Jewish Health System, New Hyde Park, NY, USA;5. Oncology Research & Development, GlaxoSmithKline, Philadelphia, PA, USA;6. Cancer Detection, Prevention and Control Program, Duke University, Durham, NC, USA;7. Division of Clinical and Epidemiologic Research, Department of Obstetrics and Gynecology, Duke University, Durham, NC, USA
Abstract:
Keywords:metabolic syndrome  prostate cancer  prostate‐specific antigen
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号